Height and Body Mass Index As Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study.
Frank Qian,Shengfeng Wang,Jonathan Mitchell,Lesley McGuffog,Daniel Barrowdale,Goska Leslie,Jan C Oosterwijk,Wendy K Chung,D Gareth Evans,Christoph Engel,Karin Kast,Cora M Aalfs,Muriel A Adank,Julian Adlard,Bjarni A Agnarsson,Kristiina Aittomäki,Elisa Alducci,Irene L Andrulis,Banu K Arun,Margreet G E M Ausems,Jacopo Azzollini,Emmanuelle Barouk-Simonet,Julian Barwell,Muriel Belotti,Javier Benitez,Andreas Berger,Ake Borg,Angela R Bradbury,Joan Brunet,Saundra S Buys,Trinidad Caldes,Maria A Caligo,Ian Campbell,Sandrine M Caputo,Jocelyne Chiquette,Kathleen B M Claes,J Margriet Collée,Fergus J Couch,Isabelle Coupier,Mary B Daly,Rosemarie Davidson,Orland Diez,Susan M Domchek,Alan Donaldson,Cecilia M Dorfling,Ros Eeles,Lidia Feliubadaló,Lenka Foretova,Jeffrey Fowler,Eitan Friedman,Debra Frost,Patricia A Ganz,Judy Garber,Vanesa Garcia-Barberan,Gord Glendon,Andrew K Godwin,Encarna B Gómez Garcia,Jacek Gronwald,Eric Hahnen,Ute Hamann,Alex Henderson,Carolyn B Hendricks,John L Hopper,Peter J Hulick,Evgeny N Imyanitov,Claudine Isaacs,Louise Izatt,Ángel Izquierdo,Anna Jakubowska,Katarzyna Kaczmarek,Eunyoung Kang,Beth Y Karlan,Carolien M Kets,Sung-Won Kim,Zisun Kim,Ava Kwong,Yael Laitman,Christine Lasset,Min Hyuk Lee,Jong Won Lee,Jihyoun Lee,Jenny Lester,Fabienne Lesueur,Jennifer T Loud,Jan Lubinski,Noura Mebirouk,Hanne E J Meijers-Heijboer,Alfons Meindl,Austin Miller,Marco Montagna,Thea M Mooij,Patrick J Morrison,Emmanuelle Mouret-Fourme,Katherine L Nathanson,Susan L Neuhausen,Heli Nevanlinna,Dieter Niederacher,Finn C Nielsen,Robert L Nussbaum,Kenneth Offit,Edith Olah,Kai-Ren Ong,Laura Ottini,Sue K Park,Paolo Peterlongo,Georg Pfeiler,Catherine M Phelan,Bruce Poppe,Nisha Pradhan,Paolo Radice,Susan J Ramus,Johanna Rantala,Mark Robson,Gustavo C Rodriguez,Rita K Schmutzler,Christina G Hutten Selkirk,Payal D Shah,Jacques Simard,Christian F Singer,Johanna Sokolowska,Dominique Stoppa-Lyonnet,Christian Sutter,Yen,R Manuel Teixeira,Soo H Teo,Mary Beth Terry,Mads Thomassen,Marc Tischkowitz,Amanda E Toland,Katherine M Tucker,Nadine Tung,Christi J van Asperen,Klaartje van Engelen,Elizabeth J van Rensburg,Shan Wang-Gohrke,Barbara Wappenschmidt,Jeffrey N Weitzel,Drakoulis Yannoukakos,GEMO Study Collaborators,HEBON,EMBRACE,Mark H Greene,Matti A Rookus,Douglas F Easton,Georgia Chenevix-Trench,Antonis C Antoniou,David E Goldgar,Olufunmilayo I Olopade,Timothy R Rebbeck,Dezheng Huo
DOI: https://doi.org/10.1093/jnci/djy132
2019-01-01
Journal of the National Cancer Institute
Abstract:BACKGROUND:BRCA1/2 mutations confer high lifetime risk of breast cancer, although other factors may modify this risk. Whether height or body mass index (BMI) modifies breast cancer risk in BRCA1/2 mutation carriers remains unclear.METHODS:We used Mendelian randomization approaches to evaluate the association of height and BMI on breast cancer risk, using data from the Consortium of Investigators of Modifiers of BRCA1/2 with 14 676 BRCA1 and 7912 BRCA2 mutation carriers, including 11 451 cases of breast cancer. We created a height genetic score using 586 height-associated variants and a BMI genetic score using 93 BMI-associated variants. We examined both observed and genetically determined height and BMI with breast cancer risk using weighted Cox models. All statistical tests were two-sided.RESULTS:Observed height was positively associated with breast cancer risk (HR = 1.09 per 10 cm increase, 95% confidence interval [CI] = 1.0 to 1.17; P = 1.17). Height genetic score was positively associated with breast cancer, although this was not statistically significant (per 10 cm increase in genetically predicted height, HR = 1.04, 95% CI = 0.93 to 1.17; P = .47). Observed BMI was inversely associated with breast cancer risk (per 5 kg/m2 increase, HR = 0.94, 95% CI = 0.90 to 0.98; P = .007). BMI genetic score was also inversely associated with breast cancer risk (per 5 kg/m2 increase in genetically predicted BMI, HR = 0.87, 95% CI = 0.76 to 0.98; P = .02). BMI was primarily associated with premenopausal breast cancer.CONCLUSION:Height is associated with overall breast cancer and BMI is associated with premenopausal breast cancer in BRCA1/2 mutation carriers. Incorporating height and BMI, particularly genetic score, into risk assessment may improve cancer management.